FDA Adverse Event Malfunction Summary report: N

SPINNING SPIROS CLOSED MALE LUER, RED CAP

MDR report key: 10635836 · Received October 6, 2020

Report

Report Number
9617594-2020-00430
Event Type
Malfunction
Date Received
October 6, 2020
Date of Event
September 24, 2020
Report Date
September 25, 2020
Manufacturer
ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V.
Product Code
FPA
UDI-DI
00840619026615
PMA / PMN Number
K082806
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 0

H10: NO PRODUCT SAMPLES, VIDEOS, OR PHOTOGRAPHS WERE RETURNED FOR INVESTIGATION. THE DEVICE HISTORY REVIEW FOR LOT 4896004 WAS REVIEWED AND A POPPET SUB-COMPONENT WAS FOUND THAT HAD A MOLDING ANOMALY ON THE SEALING SURFACE THAT CAN LEAD TO LEAKAGE. THE REPORTED COMPLAINT OF A LEAKING SPIROS CAN BE CONFIRMED. THE PROBABLE CAUSE OF THE LEAKING SPIROS IS DUE TO A MOLDING ANOMALY ON THE SEALING SURFACE OF THE POPPET SUB-COMPONENT.

Additional Manufacturer Narrative · 1

THE DEVICE IS NOT AVAILABLE FOR EVALUATION. WITHOUT THE RETURN OF THE SAMPLE A COMPREHENSIVE FAILURE INVESTIGATION CANNOT BE PERFORMED AND A CAUSE CANNOT BE DETERMINED.

Description of Event or Problem · 1

THE CUSTOMER REPORTED A SPINNING SPIROS CLOSED MALE LUER, RED CAP THAT WHEN APPLIED ON THE SYRINGE CONTAINING THE DRUG TO BE ADMINISTERED, AFTER THE CONNECTION TO THE NEEDLESS, AT THE TIME OF ASPIRATION (PERFORMED TO CHECK THE BLOOD RETURN) THE SYRINGE HAS DRAWN AIR INTO IT. AT THE TIME OF THE INJECTION, THE DRUG LEAKED FROM THE SPIROS, WETTING THE PATIENT'S SKIN AND CAUSING ENVIRONMENTAL CONTAMINATION. THE DRUG TO BE ADMINISTERED WAS DOXORUBICIN. THE CONSEQUENCES OF THE EVENT WAS THE DECONTAMINATION OF THE PATIENT AND OF THE ENVIRONMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1103906 SPINNING SPIROS CLOSED MALE LUER, RED CAP SET, ADMINISTRATION, INTRAVASCULAR FPA ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. 4896004 00840619026615

Patients

Seq Age Sex Outcome Treatment
1 49 YR DOXORUBICIN, MFR UNK| UNSP SYRINGE, UNK MFR| DOXORUBICIN, MFR UNK| UNSP SYRINGE, UNK MFR